Earlier, President Trump stated that companies without factories in the U.S. would face 100% tariffs on their pharmaceuticals ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene therapies. This new enti ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Health Biotech Limited (Health Biotech), a research and development-driven pharmaceutical company from India, successfully ...

Health Biotech Limited, an Indian pharmaceutical company, successfully showcased its innovative products at CPHI Frankfurt 2025, a notable global pharmaceutical event. The company, celebrated for its ...

Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo!

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.

Bharat Biotech expands into advanced biologics with Nucelion Therapeutics, a new CRDMO for cell and gene therapy ...

The "European Pharmaceutical Directory 2025" directory has been added to ResearchAndMarkets.com's offering. The market potential of the European biotechnology and pharmaceutical sector is enormous ...